Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Mylan has received final approval from the FDA for its abbreviated new drug application for ropinirole hydrochloride tablets, 0.25mg, 0.5mg, 1mg, 2mg, 3mg, 4mg and 5mg.
Subscribe to our email newsletter
Ropinirole hydrochloride tablets are indicated for the treatment of moderate-to-severe primary restless leg syndrome.
Ropinirole hydrochloride tablets are the generic version of GlaxoSmithKline’s Requip tablets. This product will be shipped immediately.